Document Type: RESEARCH PAPER
Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran
Background: There is no consensus regarding the best method of reconstruction in pediatric population following the
wide resection of malignant bone tumors. More exploration of the complications of osteoarticular reconstruction leads to
less existing controversy of this type of reconstruction, which is the main point of this article.
Methods: Long-term outcomes and complications of osteoarticular allograft reconstruction of primary distal femoral bone
sarcomas in 22 children with mean age of 10.7 years old were reviewed in this study. Musculoskeletal Tumor Society
(MSTS) scoring system was used for functional evaluation of the allografts.
Results: With an average follow-up time of 81 months, the outcomes of 16 patients with allografts at the final follow up
were evaluated. As expected, Limb length discrepancy (LLD) was observed in all patients (mean LLD= 2.73cm), which
was significantly correlated to allograft survival time (P<0.001). Degenerative joint disease (DJD) was also seen in all
patients and its grade was also significantly correlated to allograft survival time (P<0.001). The mean MSTS-score was
74% at the latest follow-up, ranging from 60% to 90%. Five and 10 year survival rate of allografts were found to be 93.3%
and 62.2%, respectively.
Conclusion: Osteoarticular allograft reconstruction could result in several complications including DJD. Despite its
considerable biologic advantage over endoprosthesis, osteoarticular allograft reconstruction is a long-lasting but still a
temporary solution before performing megaprosthesis. This allows patients to preserve their remaining physis for limb
growth and become old enough for an adult megaprosthesis.